The following is a summary of “Role of the advanced lung cancer inflammation index (ALI) in the risk of liver fibrosis and mortality among US adult MAFLD patients: a cross-sectional study of NHANES 1999–2018,” published in the March 2025 issue of BMC Gastroenterology by Yu et al. Metabolic dysfunction-associated fatty liver disease (MAFLD) is a […]
The post Association of ALI with Liver Fibrosis and Mortality in MAFLD first appeared on Physician’s Weekly.
